IPO registrations (S-1, F-1) · Registrants

GENVEC INC

SEC CIK
934473 · filings on EDGAR ↗
Registration
Form S-1, first filed 1998-04-30, last 2000-12-11; 2 initial registrations, 10 amendments
Outcome
Final prospectus filed 2000-12-12; withdrawal requested 1998-08-03
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
910 CLOPPER ROAD, SUITE 220N, Gaithersburg, MD 20878
EIN
23-2705690
EDGAR entity type
operating
Insiders and CEO pay
GENVEC INC on the corporate pages

Offering terms

Proposed price range
$11.00–$12.00 per share (S-1/A filed 2000-12-11)
Final price
$11.88 per share, within the range (424B1 filed 2000-12-12, an initial public offering)
Shares sold
4,000,000
Gross proceeds
$47,500,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol GNVC
Lead underwriters
J.P. Morgan (1,980,000 shares)
Syndicate
UBS (1,260,000); A.G. Edwards (360,000); Wachovia (80,000); Jackson Securities Incorporated (80,000); McDonald Investments Inc., A KeyCorp Company (80,000); Legg Mason (80,000); Needham & Company (80,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 15

FiledFormWhat it isName as filedEDGAR
1998-04-30S-1S-1 (registration)GENVEC INC0001012870-98-001149 ↗
1998-05-22S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001416 ↗
1998-06-03S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001497 ↗
1998-06-05S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001515 ↗
1998-06-19S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001635 ↗
1998-06-23S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001659 ↗
1998-06-25S-1/AS-1/A (amendment)GENVEC INC0001012870-98-001684 ↗
1998-08-03RWRW (withdrawal request)GENVEC INC0001012870-98-001946 ↗
1998-08-03RWRW (withdrawal request)GENVEC INC0001012870-98-001947 ↗
2000-10-05S-1S-1 (registration)GENVEC INC0000912057-00-043894 ↗
2000-11-14S-1/AS-1/A (amendment)GENVEC INC0000912057-00-050023 ↗
2000-11-28S-1/AS-1/A (amendment)GENVEC INC0000912057-00-051478 ↗
2000-12-07S-1/AS-1/A (amendment)GENVEC INC0000912057-00-052576 ↗
2000-12-11S-1/AS-1/A (amendment)GENVEC INC0000912057-00-052882 ↗
2000-12-12424B1424B1 (final prospectus)GENVEC INC0000912057-00-053198 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-12-11S-1/Aregistration statement$11.00–$12.00$14.384,000,000$57,500,000Nasdaq GNVC3primary document; range, price sentence, shares headline, proceeds computed, cover names 3document ↗
2000-12-12424B1final prospectus$11.884,000,000$47,500,000Nasdaq GNVC8primary document; price sentence, shares headline, proceeds computed, underwriting table 8, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Davis Thomas AndrewOfficerChief Medical Officer22006
CHURCH JEFFREY WAYNEOfficerCFO12006
FISCHER PAUL HDirector,Officer; OfficerChief Executive Officer; President & CEO; President, CEO112006–2012
KING CHARLES RICHTEROfficerSenior Vice President; Senior V.P. Research42006–2009
Butman Bryan TOfficerSenior Vice President; Senior VP, Development; Sr. Vice President; SVP, Development172006–2017
Patel Nita UOfficerVice President22006–2007
Wesdyk Russell POfficerVice President12006
HACKMAN FRANKLIN BARBARADirector12006
HOCKMEYER WAYNE TDirector122006–2017
HOROVITZ ZOLA PDirector102006–2013
KELLEY WILLAM NDirector122006–2017
PAPADOPOULOS STELIOSDirector12006
RUCH JOSHUADirector72006–2010
WERNER HAROLD RDirector22006–2007
Swirsky Douglas JDirector,Officer; OfficerChief Financial Officer; President and CEO; President & CEO; Senior Vice President & CFO242006–2017
Thornton Mark OwensOfficerSenior Vice President; Senior VP, Product Development; Sr. Vice President92006–2010
Schneebaum Marc RDirector142007–2017
Rooney Kevin MDirector82008–2012person page Fuzzy
CONNOR EDWARD MDirector42011–2012
MAHMOUD ADELDirector42011–2012
Brough Douglas EOfficerChief Scientific Officer; Senior VP, Research; SVP, Research; VP, Research92011–2017
Tucker Michael COfficerVP, Legal Affairs and Strategy22011–2012
Collins CynthiaDirector,OfficerPresident & CEO32012–2013
Loren StefanDirector102013–2017
EcoR1 Capital Fund, L.P.Other; TenPercentOwner32013–2014
EcoR1 Capital, LLCTenPercentOwner32013–2014
NODELMAN OLEGTenPercentOwner32013–2014
EcoR1 Capital Fund Qualified, L.P.Other32014
Mallette Quinterol JDirector62014–2017
Lambert James VincentOfficerSr. Director, Corp Controller; VP, Accounting & Finance52014–2017
Richman MichaelDirector52015–2017
MMCAP International Inc. SPCTenPercentOwner22017

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerGENVEC INCSEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorGENVEC. INC.EIN (EXACT)
Federal award recipientGENVEC, INC.Federal spending (USAspending)name and state
Person pageKevin M RooneyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.